查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1370915

腸內餵食配方奶粉市場- 2018-2028年全球產業規模、佔有率、趨勢、機會和預測，按產品、按流程類型、按階段、按適應症、按最終用途、按地區、按競爭細分

Enteral Feeding Formulas Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Product, By Flow Type, By Stage, By Indication, By End-Use, By Region, By Competition
出版日期: | 出版商: TechSci Research | 英文 177 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2022年，全球腸內餵食配方奶粉市場估值達到58.9億美元，預計在預測期內將穩定成長，預計年複合成長率（CAGR）為6.81%，到2028年預計將達到88.3億美元。全球醫療保健產業正在經歷重大轉型，人們越來越重視全面的病患照護。營養是患者健康的重要方面，對於因健康狀況而無法口服食物的個體來說，腸內餵食配方奶粉已成為重要的解決方案。全球腸內餵食配方奶粉市場在確保從早產兒到老年患者的個人獲得恢復和整體健康所需的重要營養方面發揮著關鍵作用。

腸內餵食涉及透過管子將營養物質直接輸送到胃腸道。當個體因吞嚥障礙、消化問題或重症而面臨口服食物消耗的挑戰時，可以採用這種方法。腸內餵食配方食品，也稱為腸內營養或管飼配方食品，是含有大量營養素、維生素和礦物質的均衡混合物的專用液體溶液。這些配方奶粉旨在滿足從嬰兒到成人的不同患者群體的特定營養需求。它們可以分為多種類型，包括標準配方、針對特定疾病的配方以及針對特定醫療狀況（例如糖尿病或腎衰竭）量身定做的特殊配方。

全球人口老化很容易出現各種健康狀況，進而影響他們正常飲食的能力。這導致對老年人營養需求量身定做的腸內餵食配方奶粉的需求增加。癌症、神經系統疾病和胃腸道疾病等慢性疾病通常會影響患者食用固體食物的能力。在這種情況下，腸內餵食配方食品提供了提供必需營養素的有效方法。由於配方奶粉成分的進步、針對特定疾病的配方奶粉的開發以及管飼技術的創新，市場不斷擴大。這些發展使腸內營養更加可行和有效，從而促進了市場成長。

市場概況
預測期 2024-2028
2022 年市場規模 58.9億美元
2028 年市場規模 88.3億美元
2023-2028 年年複合成長率 6.81%
成長最快的細分市場 胃腸道疾病
最大的市場 北美洲

主要市場促進因素：

  • 1.慢性病盛行率上升：慢性病具有病程長、進展緩慢的特點，已成為全球發病和死亡的主要原因。腸內餵食配方奶粉的需求不斷成長，已成為慢性病管理的重要組成部分，推動了全球腸內餵食配方奶粉市場的擴張。生活方式的改變、城市化、人口老化以及菸草使用、不健康飲食、缺乏身體活動和過量飲酒等風險因素導致了慢性病的激增。腸內餵食配方奶粉，也稱為管飼配方奶粉，是一種營養產品，旨在為無法口服攝取足夠營養的人直接向胃腸道提供必需營養。這些配方透過放置在胃或腸中的管子進行施用，確保個人獲得維持健康和福祉所需的營養。
  • 2.人口老化加劇：隨著世界人口持續老化，老年人口比例不斷增加，全球醫療健康產業面臨新的挑戰和機會。受這種人口變化影響的關鍵領域之一是腸內餵食配方市場。腸內餵食涉及直接向消化系統提供營養，這對於老年人的健康至關重要，因為老年人可能因各種健康狀況而難以攝取適當的營養。這導致了全球腸內餵食配方奶粉市場的興起，該行業正在迅速擴張，以滿足人口老化的需求。

主要市場挑戰：

  • 1.監管障礙：腸內餵食配方奶粉市場面臨的主要挑戰之一是複雜的監管環境。不同的國家有不同的法規和標準來管理這些產品的生產、標籤和行銷。製造商必須應對一系列法規，以確保其產品符合當地法律，同時滿足全球品質標準。這不僅增加了營運複雜性，而且還為希望在市場上立足的新進入者設置了障礙。
  • 2.成本限制：腸內餵食配方奶粉通常比普通食品更昂貴，這主要是由於其成分和生產過程的特殊性。費用可能成為患者的重大負擔，尤其是需要長期腸內餵食解決方案的患者。此外，隨著醫療保健提供者和保險公司尋求具有成本效益的選擇，成本限制可能會給製造商帶來定價壓力。對於製造商和患者來說，在負擔能力和品質之間取得平衡成為一個重大挑戰。
  • 3.營養客製化：需要腸內餵食的患者根據其醫療狀況、年齡和整體健康狀況有不同的營養需求。開發可自訂的配方來滿足這些獨特的要求是一項挑戰。製造商需要投資研發，創造出不僅營養均衡而且可以針對個別患者量身訂製的產品。在保持生產效率和成本效益的同時實現這種程度的客製化可能是一種微妙的平衡行為。
  • 4.意識和教育有限：儘管腸內餵食配方在患者護理中發揮關鍵作用，但醫療保健專業人員、患者和護理人員的意識和教育往往有限。這種認知的缺乏可能導致使用不當、劑量不正確和營養支持不足。醫療保健專業人員可能沒有接受過充分的培訓，無法根據特定患者的需求開出正確的配方。加強教育和宣傳工作對於確保正確使用這些產品和改善患者治療效果至關重要。
  • 5.競爭與創新：腸內餵食配方奶粉市場競爭激烈，許多廠商爭奪市場佔有率。這種競爭可以推動創新，但也帶來挑戰。由於製造商努力使自己與眾不同，因此存在推出沒有足夠臨床證據或研究支持其主張的產品的風險。平衡創新與嚴格的科學驗證對於維護病人安全和市場誠信至關重要。

主要市場趨勢：

  • 1.技術進步：腸內餵食配方領域的技術進步徹底改變了產品開發和管理方法。創新使得高度專業化和營養先進的腸內餵食配方的誕生成為可能，旨在滿足患有各種疾病的患者的特定營養需求。精確的配方和生物活性成分的加入有助於患者更好的康復和整體健康。包括可編程幫浦在內的尖端輸送系統可確保精確的營養輸送，減少併發症。物聯網 (IoT) 技術催生了智慧餵食幫浦和監控設備，可傳輸即時患者資料，從而增強臨床決策。人工智慧 (AI) 和機器學習演算法根據患者資料推薦客製化的餵食配方和時間表。
  • 2.細分市場洞察 - 產品：2022 年，標準配方奶粉細分市場佔據主導地位，預計將繼續擴大。標準腸內餵食配方奶粉的配製是為了滿足廣大患者的一般營養需求，遵循既定的營養指南，並提供適合大多數患者的常量營養素和微量營養素的均衡組合，沒有特定的飲食限制或醫療條件。支持其安全性和有效性的臨床證據使它們成為醫療保健提供者的首選。
  • 3.細分市場洞察 - 流量類型：2022 年，間歇餵料流量細分市場佔據主導地位，預計將繼續擴大。間歇餵食涉及在一天中的特定時段提供營養，使患者可以有更長的時間不使用飼管。與連續餵食相比，這可以提高患者的舒適度和耐受性，提高生活品質並符合自然飲食模式。

區域洞察 - 北美：北美人口的老年人口正在顯著增加。由於與年齡相關的健康問題，老年人通常更有可能需要腸內營養。這種需求促進了腸道的成長

目錄

第 1 章：產品概述

  • 市場定義
  • 市場範圍
    • 涵蓋的市場
    • 研究年份
    • 主要市場區隔

第 2 章：研究方法

  • 研究目的
  • 基線方法
  • 主要產業夥伴
  • 主要協會和二手資料來源
  • 預測方法
  • 數據三角測量與驗證
  • 假設和限制

第 3 章：執行摘要

  • 市場概況
  • 主要市場細分概述
  • 主要市場參與者概述
  • 重點地區/國家概況
  • 市場促進因素、挑戰、趨勢概述

第 4 章：客戶之聲

第 5 章：全球腸內餵食配方奶粉市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依產品（標準配方、特定疾病配方）
    • 依流量類型（間歇給料流、連續給料流）
    • 依階段（成人、兒童）
    • 依適應症（阿茲海默症、營養缺乏、癌症照護、糖尿病、慢性腎臟病、孤兒疾病、吞嚥困難、疼痛管理、吸收不良/胃腸道疾病/腹瀉、其他）
    • 依最終用途（醫院、家庭護理）
    • 按地區
    • 按公司分類（前 5 名市場參與者的股份）
  • 市場地圖
    • 按產品分類
    • 按流量類型
    • 按階段
    • 按指示
    • 按最終用途
    • 按地區

第 6 章：北美腸內餵食配方奶粉市場前景

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品分類
    • 按流量類型
    • 按階段
    • 按指示
    • 按最終用途
    • 按國家/地區

第 7 章：歐洲腸內餵食配方奶粉市場前景

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品分類
    • 按流量類型
    • 按階段
    • 按指示
    • 按最終用途
    • 按國家/地區

第 8 章：亞太地區腸內餵食配方奶粉市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品分類
    • 按流量類型
    • 按階段
    • 按指示
    • 按最終用途
    • 按國家/地區

第 9 章：南美洲腸內餵食配方奶粉市場前景

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按類型
    • 按流量類型
    • 按階段
    • 按指示
    • 按最終用途
    • 按國家/地區

第 10 章：中東和非洲腸內餵食配方奶粉市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按類型
    • 按流量類型
    • 按階段
    • 按指示
    • 按最終用途
    • 按國家/地區

第 11 章：市場動態

  • 促進要素
  • 挑戰

第 12 章：市場趨勢與發展

  • 近期發展
  • 併購
  • 產品發布

第13章：競爭格局

  • 雅培
  • 達能公司
  • 費森尤斯·卡比股份公司
  • 雀巢
  • 維克圖斯
  • 普里姆斯製藥公司
  • 明治控股。有限公司。
  • 美贊臣公司

第 14 章：策略建議

第 15 章：關於我們與免責聲明

簡介目錄
Product Code: 17206

The Global Enteral Feeding Formulas Market reached a valuation of USD 5.89 Billion in 2022 and is expected to experience steady growth in the forecast period, with a projected Compound Annual Growth Rate (CAGR) of 6.81% and expected to reach USD 8.83 Billion by 2028. The global healthcare industry is undergoing a significant transformation, with a growing emphasis on comprehensive patient care. Nutrition is a critical aspect of patient well-being, and for individuals unable to consume food orally due to medical conditions, enteral feeding formulas have emerged as an essential solution. The Global Enteral Feeding Formulas Market plays a pivotal role in ensuring that individuals, ranging from premature infants to elderly patients, receive the vital nutrients required for recovery and overall health.

Enteral feeding involves delivering nutrients directly into the gastrointestinal tract via a tube. This method is employed when individuals face challenges in oral food consumption due to conditions like swallowing disorders, digestive issues, or critical illness. Enteral feeding formulas, also known as enteral nutrition or tube feeding formulas, are specialized liquid solutions containing a balanced mix of macronutrients, vitamins, and minerals. These formulas are designed to match the specific nutritional needs of different patient groups, spanning from infants to adults. They can be categorized into various types, including standard formulas, disease-specific formulas, and specialized formulations tailored to specific medical conditions such as diabetes or renal failure.

The aging global population is prone to various health conditions that can hinder their ability to eat normally. This has led to an increased demand for enteral feeding formulas customized to the nutritional needs of the elderly. Chronic conditions such as cancer, neurological disorders, and gastrointestinal diseases often affect a patient's capacity to consume solid food. In such cases, enteral feeding formulas provide an effective means of delivering essential nutrients. The market has expanded due to advancements in formula compositions, the development of disease-specific formulas, and innovations in tube-feeding techniques. These developments have made enteral nutrition more viable and effective, thereby contributing to market growth.

Market Overview
Forecast Period2024-2028
Market Size 2022USD 5.89 Billion
Market Size 2028USD 8.83 Billion
CAGR 2023-20286.81%
Fastest Growing SegmentGastrointestinal Diseases
Largest MarketNorth America

Key Market Drivers:

  • 1. Rising Prevalence of Chronic Diseases: Chronic diseases, characterized by their long duration and slow progression, have become a leading cause of morbidity and mortality worldwide. The growing demand for enteral feeding formulas has emerged as a vital component in the management of chronic diseases, driving the expansion of the global enteral feeding formulas market. Lifestyle changes, urbanization, an aging population, and risk factors such as tobacco use, unhealthy diets, physical inactivity, and excessive alcohol consumption have contributed to the surge in chronic diseases. Enteral feeding formulas, also known as tube feeding formulas, are nutritional products designed to provide essential nutrients directly into the gastrointestinal tract for individuals who cannot consume sufficient nutrients orally. These formulas are administered through tubes placed in the stomach or intestines, ensuring that individuals receive the required nutrients to maintain their health and well-being.
  • 2. Increasing Aging Population: As the world's population continues to age, with a growing proportion of elderly individuals, the global healthcare industry is facing new challenges and opportunities. One of the key areas impacted by this demographic shift is the enteral feeding formulas market. Enteral feeding, which involves providing nutrition directly into the digestive system, has become crucial for the well-being of elderly individuals who may struggle with proper nutrition intake due to various health conditions. This has led to the rise of the global enteral feeding formulas market, a sector that is rapidly expanding to meet the needs of an aging population.

Key Market Challenges:

  • 1. Regulatory Hurdles: One of the primary challenges confronting the enteral feeding formulas market is the complex regulatory landscape. Different countries have varying regulations and standards governing the production, labeling, and marketing of these products. Manufacturers must navigate a maze of regulations to ensure their products comply with local laws while also meeting global quality standards. This not only increases operational complexity but also poses a barrier for new entrants looking to establish themselves in the market.
  • 2. Cost Constraints: Enteral feeding formulas are often more expensive than regular food, primarily due to the specialized nature of their composition and production process. The cost can become a significant burden for patients, especially those requiring long-term enteral feeding solutions. Additionally, cost constraints may lead to pricing pressures for manufacturers as healthcare providers and insurers seek cost-effective options. Striking a balance between affordability and quality becomes a significant challenge for both manufacturers and patients.
  • 3. Nutritional Customization: Patients requiring enteral feeding have diverse nutritional needs based on their medical condition, age, and overall health. Developing formulas that can be customized to meet these unique requirements is a challenge. Manufacturers need to invest in research and development to create products that are not only nutritionally balanced but can also be tailored to individual patients. Achieving this level of customization while maintaining production efficiency and cost-effectiveness can be a delicate balancing act.
  • 4. Limited Awareness and Education: Despite the critical role enteral feeding formulas play in patient care, there is often limited awareness and education among healthcare professionals, patients, and caregivers. This lack of awareness can lead to improper usage, incorrect dosing, and inadequate nutritional support. Healthcare professionals may not be adequately trained to prescribe the right formula for specific patient needs. Increasing education and awareness efforts are essential to ensure proper utilization of these products and improve patient outcomes.
  • 5. Competition and Innovation: The enteral feeding formulas market is competitive, with numerous manufacturers vying for market share. This competition can drive innovation, but it also presents challenges. As manufacturers strive to differentiate themselves, there is a risk of introducing products without sufficient clinical evidence or research to support their claims. Balancing innovation with rigorous scientific validation is crucial to maintain patient safety and uphold the integrity of the market.

Key Market Trends:

  • 1. Technological Advancements: Technological advancements in the field of enteral feeding formulas have revolutionized product development and administration methods. Innovations have enabled the creation of highly specialized and nutritionally advanced enteral feeding formulas designed to cater to the specific nutritional requirements of patients with various medical conditions. Precise formulation and the inclusion of bioactive ingredients contribute to better patient recovery and overall health. Cutting-edge delivery systems, including programmable pumps, ensure precise nutrient delivery, reducing complications. Internet of Things (IoT) technology has led to smart feeding pumps and monitoring devices that transmit real-time patient data, enhancing clinical decision-making. Artificial intelligence (AI) and machine learning algorithms recommend tailored feeding formulas and schedules based on patient data.
  • 2. Segmental Insights - Product: In 2022, the Standard Formula segment dominated the market and is predicted to continue expanding. Standard enteral feeding formulas are formulated to meet the general nutritional needs of a wide range of patients, adhering to established nutritional guidelines and offering a balanced combination of macronutrients and micronutrients suitable for most patients without specific dietary restrictions or medical conditions. The availability of clinical evidence supporting their safety and efficacy makes them a preferred choice for healthcare providers.
  • 3. Segmental Insights - Flow Type: In 2022, the Intermittent Feeding Flow segment dominated the market and is predicted to continue expanding. Intermittent feeding involves providing nutrients over specific periods during the day, allowing patients to have longer periods without the feeding tube in use. This can improve patient comfort and tolerance compared to continuous feeding, enhancing quality of life and aligning with natural eating patterns.

Regional Insights - North America: The North American population is experiencing a significant increase in the elderly population. Elderly individuals often have a higher likelihood of requiring enteral nutrition due to age-related health issues. This demand has contributed to the growth of the enteral

feeding formulas market in the region. North America, particularly the United States, possesses a well-developed and sophisticated healthcare infrastructure, ensuring easy access to enteral feeding formulas for patients in need. The region also sees a high prevalence of chronic diseases, further driving demand for these products.

Key Market Players

  • Abbott
  • Danone S.A
  • Fresenius Kabi AG
  • Nestle
  • VICTUS
  • Primus Pharmaceuticals, Inc.
  • Meiji Holdings. Co.,Ltd.
  • Mead Johnson & Company, LLC

Report Scope:

  • In this report, the Global Enteral Feeding Formulas Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Enteral Feeding Formulas Market, By Product:

  • Standard Formula
  • Disease-specific Formulas

Enteral Feeding Formulas Market, By Flow Type:

  • Intermittent Feeding Flow
  • Continuous Feeding Flow

Enteral Feeding Formulas Market, By Stage:

  • Adults
  • Pediatrics

Enteral Feeding Formulas Market, By Indication:

  • Adults
  • Alzheimer's
  • Nutrition Deficiency
  • Cancer Care
  • Diabetes
  • Chronic Kidney Diseases
  • Orphan Diseases
  • Dysphagia, Pain Management
  • Malabsorption/GI Disorder/Diarrhea
  • Others

Enteral Feeding Formulas Market, By End-User:

  • Hospitals
  • Homecare

Enteral Feeding Formulas Market, By Region:

  • North America
  • Asia-Pacific
  • Europe
  • Middle East & Africa
  • South America

Competitive Landscape

  • Company Profiles: Detailed analysis of the major companies present in the Global Enteral Feeding Formulas Market.

Available Customizations:

  • Global Enteral Feeding Formulas Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validations
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Enteral Feeding Formulas Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Standard Formula, Disease-specific Formulas)
    • 5.2.2. By Flow Type (Intermittent Feeding Flow, Continuous Feeding Flow)
    • 5.2.3. By Stage ( Adults, Pediatrics)
    • 5.2.4. By Indication (Alzheimer's, Nutrition Deficiency, Cancer Care, Diabetes, Chronic Kidney Diseases, Orphan Diseases, Dysphagia, Pain Management, Malabsorption/GI Disorder/Diarrhea, Others)
    • 5.2.5. By End-Use (Hospitals, Homecare)
    • 5.2.6. By Region
    • 5.2.7. By Company (Shares of Top 5 Market Players)
  • 5.3. Market Map
    • 5.3.1. By Product
    • 5.3.2. By Flow Type
    • 5.3.3. By Stage
    • 5.3.4. By Indication
    • 5.3.5. By End-Use
    • 5.3.6. By Region

6. North America Enteral Feeding Formulas Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Flow Type
    • 6.2.3. By Stage
    • 6.2.4. By Indication
    • 6.2.5. By End-Use
    • 6.2.6. By Country
      • 6.2.6.1. United States Enteral Feeding Formulas Market Outlook
        • 6.2.6.1.1. Market Size & Forecast
        • 6.2.6.1.1.1. By Value
        • 6.2.6.1.2. Market Share & Forecast
        • 6.2.6.1.2.1. By Product
        • 6.2.6.1.2.2. By Flow Type
        • 6.2.6.1.2.3. By Stage
        • 6.2.6.1.2.4. By Indication
        • 6.2.6.1.2.5. By End-Use
      • 6.2.6.2. Canada Enteral Feeding Formulas Market Outlook
        • 6.2.6.2.1. Market Size & Forecast
        • 6.2.6.2.1.1. By Value
        • 6.2.6.2.2. Market Share & Forecast
        • 6.2.6.2.2.1. By Product
        • 6.2.6.2.2.2. By Flow Type
        • 6.2.6.2.2.3. By Stage
        • 6.2.6.2.2.4. By Indication
        • 6.2.6.2.2.5. By End-Use
      • 6.2.6.3. Mexico Enteral Feeding Formulas Market Outlook
        • 6.2.6.3.1. Market Size & Forecast
        • 6.2.6.3.1.1. By Value
        • 6.2.6.3.2. Market Share & Forecast
        • 6.2.6.3.2.1. By Test
        • 6.2.6.3.2.2. By Flow Type
        • 6.2.6.3.2.3. By Stage
        • 6.2.6.3.2.4. By Indication
        • 6.2.6.3.2.5. By End-Use

7. Europe Enteral Feeding Formulas Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Flow Type
    • 7.2.3. By Stage
    • 7.2.4. By Indication
    • 7.2.5. By End-Use
    • 7.2.6. By Country
      • 7.2.6.1. France Enteral Feeding Formulas Market Outlook
        • 7.2.6.1.1. Market Size & Forecast
        • 7.2.6.1.1.1. By Value
        • 7.2.6.1.2. Market Share & Forecast
        • 7.2.6.1.2.1. By Product
        • 7.2.6.1.2.2. By Flow Type
        • 7.2.6.1.2.3. By Stage
        • 7.2.6.1.2.4. By Indication
        • 7.2.6.1.2.5. By End-Use
      • 7.2.6.2. Germany Enteral Feeding Formulas Market Outlook
        • 7.2.6.2.1. Market Size & Forecast
        • 7.2.6.2.1.1. By Value
        • 7.2.6.2.2. Market Share & Forecast
        • 7.2.6.2.2.1. By Product
        • 7.2.6.2.2.2. By Flow Type
        • 7.2.6.2.2.3. By Stage
        • 7.2.6.2.2.4. By Indication
        • 7.2.6.2.2.5. By End-Use
      • 7.2.6.3. United Kingdom Enteral Feeding Formulas Market Outlook
        • 7.2.6.3.1. Market Size & Forecast
        • 7.2.6.3.1.1. By Value
        • 7.2.6.3.2. Market Share & Forecast
        • 7.2.6.3.2.1. By Product
        • 7.2.6.3.2.2. By Flow Type
        • 7.2.6.3.2.3. By Stage
        • 7.2.6.3.2.4. By Indication
        • 7.2.6.3.2.5. By End-Use
      • 7.2.6.4. Italy Enteral Feeding Formulas Market Outlook
        • 7.2.6.4.1. Market Size & Forecast
        • 7.2.6.4.1.1. By Value
        • 7.2.6.4.2. Market Share & Forecast
        • 7.2.6.4.2.1. By Product
        • 7.2.6.4.2.2. By Flow Type
        • 7.2.6.4.2.3. By Stage
        • 7.2.6.4.2.4. By Indication
        • 7.2.6.4.2.5. By End-Use
      • 7.2.6.5. Spain Enteral Feeding Formulas Market Outlook
        • 7.2.6.5.1. Market Size & Forecast
        • 7.2.6.5.1.1. By Value
        • 7.2.6.5.2. Market Share & Forecast
        • 7.2.6.5.2.1. By Product
        • 7.2.6.5.2.2. By Flow Type
        • 7.2.6.5.2.3. By Stage
        • 7.2.6.5.2.4. By Indication
        • 7.2.6.5.2.5. By End-Use

8. Asia Pacific Enteral Feeding Formulas Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Flow Type
    • 8.2.3. By Stage
    • 8.2.4. By Indication
    • 8.2.5. By End-Use
    • 8.2.6. By Country
      • 8.2.6.1. China Enteral Feeding Formulas Market Outlook
        • 8.2.6.1.1. Market Size & Forecast
        • 8.2.6.1.1.1. By Value
        • 8.2.6.1.2. Market Share & Forecast
        • 8.2.6.1.2.1. By Product
        • 8.2.6.1.2.2. By Flow Type
        • 8.2.6.1.2.3. By Stage
        • 8.2.6.1.2.4. By Indication
        • 8.2.6.1.2.5. By End-Use
      • 8.2.6.2. India Enteral Feeding Formulas Market Outlook
        • 8.2.6.2.1. Market Size & Forecast
        • 8.2.6.2.1.1. By Value
        • 8.2.6.2.2. Market Share & Forecast
        • 8.2.6.2.2.1. By Product
        • 8.2.6.2.2.2. By Flow Type
        • 8.2.6.2.2.3. By Stage
      • 8.2.6.3. South Korea Enteral Feeding Formulas Market Outlook
        • 8.2.6.3.1. Market Size & Forecast
        • 8.2.6.3.1.1. By Value
        • 8.2.6.3.2. Market Share & Forecast
        • 8.2.6.3.2.1. By Product
        • 8.2.6.3.2.2. By Flow Type
        • 8.2.6.3.2.3. By Stage
        • 8.2.6.3.2.4. By Indication
        • 8.2.6.3.2.5. By End-Use
      • 8.2.6.4. Japan Enteral Feeding Formulas Market Outlook
        • 8.2.6.4.1. Market Size & Forecast
        • 8.2.6.4.1.1. By Value
        • 8.2.6.4.2. Market Share & Forecast
        • 8.2.6.4.2.1. By Product
        • 8.2.6.4.2.2. By Flow Type
        • 8.2.6.4.2.3. By Stage
        • 8.2.6.4.2.4. By Indication
        • 8.2.6.4.2.5. By End-Use
      • 8.2.6.5. Australia Enteral Feeding Formulas Market Outlook
        • 8.2.6.5.1. Market Size & Forecast
        • 8.2.6.5.1.1. By Value
        • 8.2.6.5.2. Market Share & Forecast
        • 8.2.6.5.2.1. By Product
        • 8.2.6.5.2.2. By Flow Type
        • 8.2.6.5.2.3. By Stage
        • 8.2.6.5.2.4. By Indication
        • 8.2.6.5.2.5. By End-Use

9. South America Enteral Feeding Formulas Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Flow Type
    • 9.2.3. By Stage
    • 9.2.4. By Indication
    • 9.2.5. By End-Use
    • 9.2.6. By Country
      • 9.2.6.1. Brazil Enteral Feeding Formulas Market Outlook
        • 9.2.6.1.1. Market Size & Forecast
        • 9.2.6.1.1.1. By Value
        • 9.2.6.1.2. Market Share & Forecast
        • 9.2.6.1.2.1. By Product
        • 9.2.6.1.2.2. By Flow Type
        • 9.2.6.1.2.3. By Stage
      • 9.2.6.2. Argentina Enteral Feeding Formulas Market Outlook
        • 9.2.6.2.1. Market Size & Forecast
        • 9.2.6.2.1.1. By Value
        • 9.2.6.2.2. Market Share & Forecast
        • 9.2.6.2.2.1. By Product
        • 9.2.6.2.2.2. By Flow Type
        • 9.2.6.2.2.3. By Stage
        • 9.2.6.2.2.4. By Indication
        • 9.2.6.2.2.5. By End-Use
      • 9.2.6.3. Colombia Enteral Feeding Formulas Market Outlook
        • 9.2.6.3.1. Market Size & Forecast
        • 9.2.6.3.1.1. By Value
        • 9.2.6.3.2. Market Share & Forecast
        • 9.2.6.3.2.1. By Product
        • 9.2.6.3.2.2. By Flow Type
        • 9.2.6.3.2.3. By Stage
        • 9.2.6.3.2.4. By Indication
        • 9.2.6.3.2.5. By End-Use

10. Middle East & Africa Enteral Feeding Formulas Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Flow Type
    • 10.2.3. By Stage
    • 10.2.4. By Indication
    • 10.2.5. By End-Use
    • 10.2.6. By Country
      • 10.2.6.1. South Africa Enteral Feeding Formulas Market Outlook
        • 10.2.6.1.1. Market Size & Forecast
        • 10.2.6.1.1.1. By Value
        • 10.2.6.1.2. Market Share & Forecast
        • 10.2.6.1.2.1. By Product
        • 10.2.6.1.2.2. By Flow Type
        • 10.2.6.1.2.3. By Stage
      • 10.2.6.2. Saudi Arabia Enteral Feeding Formulas Market Outlook
        • 10.2.6.2.1. Market Size & Forecast
        • 10.2.6.2.1.1. By Value
        • 10.2.6.2.2. Market Share & Forecast
        • 10.2.6.2.2.1. By Product
        • 10.2.6.2.2.2. By Flow Type
        • 10.2.6.2.2.3. By Stage
        • 10.2.6.2.2.4. By Indication
        • 10.2.6.2.2.5. By End-Use
      • 10.2.6.3. UAE Enteral Feeding Formulas Market Outlook
        • 10.2.6.3.1. Market Size & Forecast
        • 10.2.6.3.1.1. By Value
        • 10.2.6.3.2. Market Share & Forecast
        • 10.2.6.3.2.1. By Product
        • 10.2.6.3.2.2. By Flow Type
        • 10.2.6.3.2.3. By Stage
        • 10.2.6.3.2.4. By Indication
        • 10.2.6.3.2.5. By End-Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Competitive Landscape

  • 13.1. Abbott
  • 13.2. Danone S.A
  • 13.3. Fresenius Kabi AG
  • 13.4. Nestle
  • 13.5. VICTUS
  • 13.6. Primus Pharmaceuticals, Inc.
  • 13.7. Meiji Holdings. Co.,Ltd.
  • 13.8. Mead Johnson & Company, LLC

14. Strategic Recommendations

15. About us & Disclaimer